What’s going on here?
Gevo missed second-quarter revenue forecasts but turned a profit, powered by new carbon credit sales and rising demand for its low-carbon ethanol.
What does this mean?
Gevo reported Q2 2025 revenue of $43.41 million—$14 million higher than last quarter, but just under the $46.50 million analysts were expecting. Still, the company posted a net profit of $2.73 million, with EBIT at $5.80 million and adjusted EBITDA reaching $17 million. Operating expenses hit $37.62 million, mainly reflecting continued investment in efficiency and tech upgrades. The bright spot: Gevo’s first carbon dioxide removal credit sales added $1 million this quarter, while credits tied to low-carbon ethanol and renewable natural gas brought in $21 million over the first half of the year. With 28 million gallons of ethanol produced, steady demand and new income streams have left analysts upbeat about Gevo’s expanding footprint and cash flow.
Why should I care?
For markets: Carbon credits power up clean fuel stocks.
Gevo’s entry into carbon credit sales is helping the company stand out, with carbon dioxide removal revenue set to reach $5 million by year-end and potentially over $30 million annually in coming years. These fresh revenue streams are drawing new investor attention, and analysts currently rate the stock a ‘buy’ with a price target about 37% ahead of current levels—a standout in a sector where many competitors are under margin pressure and mostly stuck at ‘hold’ ratings.
The bigger picture: Clean fuels rise from niche to mainstream.
The shift toward low-carbon fuels is picking up speed as climate policies and corporate pledges take hold, and Gevo’s investment in sustainable aviation fuel projects puts it in a strong position. As the company moves from early-stage credit programs to more established, recurring revenue streams, it underscores a larger trend: clean fuels and environmental credits are quickly becoming core drivers for the energy sector’s next phase.
SPONSORED BY INVESTORS LAB, BY SCIENCE NEWS
Half of Wall Street’s “insider knowledge” is already outdated by the time you see it.
But if you could see the long-term signals before they made mainstream news, you’d stand a better chance of finding a revolutionary opportunity early.
Enter, Investors Lab from Science News. The publication turns cutting-edge research – across biotech, ag-tech, and beyond – into forward-focused and actionable investment insights. And it’s just $10 a month, with your first two months free.
